You are here: Industry Insights > HHS

News List

US HHS expedites development and manufacture of Covid-19 vaccines pharmaceutical-technology
April 01, 2020
The US Department of Health and Human Services (HHS) is accelerating the development and manufacture of vaccines against the Covid-19 coronavirus infection.
U.S. HHS Seeks Stakeholder COVID-19 Countermeasures contractpharma
March 20, 2020
The U.S. Department of Health & Human Services is providing a portal for the COVID-19 medical countermeasures task force ...
Sanofi Awarded $226 Million by HHS to Expand Pandemic Influenza Preparedness americanpharmaceuticalreview
December 17, 2019
Sanofi Pasteur has entered into an agreement with the U.S. Department of Health and Human Services (HHS) to increase the company's domestic pandemic influenza vaccine production ...
Emergent Awarded 10-Year HHS Contract contractpharma
September 09, 2019
In support of the U.S. government’s policy to maintain a stockpile to be able to protect every American from smallpox...
Enough hubbub about HHS' Truvada patents, Gilead says. We're challenging them at the PTO fiercepharma
August 25, 2019
Drugmakers have often lambasted the U.S. Patent and Trademark Office’s (PTO's) inter partes review system, but now Gilead Sciences is hoping to use it to its advantage.
$23m aid announced for Ebola vaccine manufacture europeanpharmaceuticalreview
August 23, 2019
The US HHS has committed to a contribution to help Merck manufacture its investigational V920 vaccine for the treatment of Ebola.
US judge blocks HHS rule to disclose drug prices in TV ads pharmaceutical-technology
July 10, 2019
US District Judge Amit Mehta has blocked a Department of Health and Human Services (HHS) rule that would have mandated drug manufacturers to disclose the list prices of their medication in television advertisements.
HHS confirms Sharpless to serve as acting FDA chief fiercepharma
March 13, 2019
After FDA commissioner Scott Gottlieb, M.D., abruptly announced his resignation a week ago, the agency has its next acting chief. Ned Sharpless, M.D., currently the director of the National Cancer Institute, is assuming the role.
Scott Gottlieb resigns as FDA commissioner pharmaceutical-technology
March 08, 2019
Scott Gottlieb has announced his resignation from the position of commissioner of the US Food and Drug Administration (FDA).
Johnson & Johnson to disclose drug prices in television ads pharmaceutical-technology
February 13, 2019
Johnson & Johnson has announced plans to disclose the price of its prescription medicines directly to customers on TV advertisements in a bid to improve transparency.....

Previous page 1 2 3 Next page